SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001280600-20-000059
Filing Date
2020-08-06
Accepted
2020-08-06 16:11:45
Documents
66
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q xlrn-20200630.htm   iXBRL 10-Q 1492851
2 EX-31.1 xlrn-20200630xexhibit3.htm EX-31.1 16138
3 EX-31.2 xlrn-20200630xexhibit31.htm EX-31.2 16203
4 EX-32.1 xlrn-20200630xexhibit32.htm EX-32.1 9465
  Complete submission text file 0001280600-20-000059.txt   6135463

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xlrn-20200630.xsd EX-101.SCH 38587
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xlrn-20200630_cal.xml EX-101.CAL 60063
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xlrn-20200630_def.xml EX-101.DEF 174560
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xlrn-20200630_lab.xml EX-101.LAB 480959
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xlrn-20200630_pre.xml EX-101.PRE 295097
10 EXTRACTED XBRL INSTANCE DOCUMENT xlrn-20200630_htm.xml XML 1136191
Mailing Address 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SIDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Filer) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36065 | Film No.: 201081730
SIC: 2836 Biological Products, (No Diagnostic Substances)